We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > aurobindo pharma

News List

Aurobindo inks pact with Advent Pharmaceuticals for $12.5 million expressbpd
November 14, 2018
Aurobindo Pharma said it’s wholly-owned subsidiary has entered into an agreement to acquire a product under development and related assets from Australia-based
Aurobindo Pharma gets nod from South African health authority for HIV drug financialexpress
September 19, 2018
Aurobindo Pharma has received approval from the South African health authority to market its Dolutegravir
Aurobindo Pharma’s generic Ertapenem Injection bags US FDA approval financialexpress
June 29, 2018
Ertapenem injection is used for the treatment of moderate to severe infections caused by susceptible bacteria
Aurobindo Pharma receives approval for Sevelamer Carbonate tabs expressbpd
July 20, 2017
Sevelamer Carbonate tablets is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis
Aurobindo Pharma buys four biosimilar products from TL Biopharmaceutical pharmaceutical-technology
February 14, 2017
Indian company Aurobindo Pharma has acquired four cell culture-derived biosimilar products from Swiss-based TL Biopharmaceutical.

Previous page 1 2 3 Next page